招商国证生物医药指数(LOF)C(012417)资产负债表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
682,873,802.00 |
| 结算备付金 |
1,437,013.63 |
1,657,130.72 |
5,240,475.20 |
4,131,506.57 |
| 存出保证金 |
519,460.87 |
328,678.28 |
388,814.63 |
1,142,349.76 |
| 交易性金融资产 |
9,483,925,432.28 |
9,171,151,212.95 |
12,324,714,667.15 |
12,232,516,888.20 |
| 其中：股票投资 |
9,274,061,333.60 |
8,842,370,317.98 |
11,898,027,050.79 |
12,218,586,947.44 |
| 债券投资 |
209,864,098.68 |
328,780,894.97 |
426,687,616.36 |
13,929,940.76 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
- |
155,067.65 |
324,169.44 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
33,723.00 |
| 应收申购款 |
18,611,631.92 |
16,670,530.00 |
27,828,412.58 |
42,519,784.98 |
| 其他资产 |
- |
19,754.72 |
150,131.20 |
69,194.81 |
| 资产总计 |
9,865,255,597.51 |
9,410,842,108.43 |
12,617,173,558.22 |
12,963,611,418.76 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
9,817,157.36 |
- |
- |
| 应付赎回款 |
40,975,481.98 |
32,840,271.61 |
37,979,813.71 |
53,615,834.69 |
| 应付管理人报酬 |
8,780,805.37 |
7,991,165.59 |
10,691,072.17 |
10,760,283.39 |
| 应付托管费 |
1,756,161.09 |
1,598,233.11 |
2,138,214.44 |
2,367,262.34 |
| 应付销售服务费 |
173,487.11 |
152,998.06 |
176,262.62 |
173,382.86 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
412.13 |
4,209.50 |
16,225.70 |
11,274.53 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
2,327,897.37 |
2,491,311.65 |
2,955,678.80 |
3,127,084.78 |
| 负债合计 |
54,014,245.05 |
54,895,346.88 |
53,957,267.44 |
70,055,122.59 |
| 所有者权益 |
| 实收基金 |
18,374,975,674.73 |
18,609,163,778.99 |
17,829,965,084.10 |
18,460,941,823.09 |
| 未分配利润 |
-8,563,734,322.27 |
-9,253,217,017.44 |
-5,266,748,793.32 |
-5,567,385,526.92 |
| 所有者权益合计 |
9,811,241,352.46 |
9,355,946,761.55 |
12,563,216,290.78 |
12,893,556,296.17 |
| 负债及所有者权益总计 |
9,865,255,597.51 |
9,410,842,108.43 |
12,617,173,558.22 |
12,963,611,418.76 |
微信公众号
证券之星APP
基本资料
